Navigation Links
MHA to Release Findings of Independent Long Term Care Member Study
Date:3/12/2008

FLORHAM PARK, N.J., March 12 /PRNewswire/ -- Managed Health Care Associates, Inc. (MHA) announces the completion of its inaugural Independent Long Term Care Member Study, the results of which will be revealed at the 2008 MHA Business Summit, March 27-28, 2008 in Las Vegas, Nevada.

The report was compiled from an electronic member survey issued in 2007 and examined self-reported data for key operational elements of Independent Long Term Care pharmacies, including pharmacy size and capacity, staffing ratios, patient mix, occupancy rates, pharmaceutical budget, use of diverse technologies, and several other categories that are critical to running a Long Term Care Pharmacy.

An overview of study results, as well as details on survey methodology, will be delivered at the conference via open forum allowing time for audience Q&A.

"We believe this study is a first of its kind and should be of great interest to all in the Long Term Care Pharmacy industry," stated Michelle Templin, MHA's Regional Vice President of Long Term Care. "As the leading group purchasing and managed care contracting organization serving LTC pharmacies, MHA is uniquely positioned to gather the statistically significant responses required to carry out this survey. Members requested this type of data to compare themselves to their peer group and to recognize opportunities to improve efficiency. With MHA's commitment to help our members compete effectively, we are pleased to have received such a high response rate to our first survey and to provide our membership with this valuable study on their pharmacies and the industry as a whole. We intend to conduct this survey annually and thus be able to identify future changes occurring within Long Term Care pharmacy."

MHA Members attending the Business Summit will receive a complimentary copy of the Independent Long Term Care Member Study. All members not in attendance will be able to request a copy of the study directly through their National Account Manager. Non-members and other interested parties can obtain copies by contacting MHA's Marketing Department.

About MHA

Managed Health Care Associates, Inc. (MHA) is the largest Alternate Site GPO in the country servicing the Long Term Care, Home Infusion, Combo Pharmacy and Specialty Pharmacy industries. MHA is also the leading Long Term Care Pharmacy Network Manager with focus on serving the Medicare D patient population. MHA's success is driven by unparalleled member support, competitive contracts, and the ability to create sophisticated, customized, web tools and reports, designed to increase savings and promote profitability. Members utilize MHA services to assist in the purchasing of a complete line of pharmaceuticals, medical supplies, capital equipment, and nutritional food, as well as network access to the majority of the largest national and regional prescription drug plans managing the Medicare Part D drug benefit. MHA also offers a variety of other services including contract administration, marketing, and continuing education. For more information, visit http://www.mhainc.com.

For More Information Contact:

Angela Elsier

Director of Marketing

Managed Health Care Associates, Inc.

800-642-3020 X2870

aelsier@mhainc.com


'/>"/>
SOURCE Managed Health Care Associates, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Hooper Holmes Announces Fourth Quarter Earnings Release Date and Conference Call Information
2. Herley Industries, Inc. Second Quarter Earnings Release and Conference Call Notice
3. Novavax Announces Release Date of 2007 Fourth Quarter, Full Year Financial Results and Investor Conference Call
4. Cardiogenesis Corporation Announces Rescheduled Fourth Quarter and Full Year 2007 Earnings Release
5. Perrigo Company to Market Over-the-Counter Cetirizine Hydrochloride, Pseudoephedrine Hydrochloride Extended-Release Tablets
6. Spheris Sets Fourth Quarter 2007 Earnings Release and Conference Call Dates
7. Somanetics Corporation to Release First Quarter 2008 Financial Results and Host Conference Call March 18, 2008
8. Report on 547 New Medicines in Development for Neurological Disorders Released in San Antonio
9. Dana Foundation releases arts and cognition research
10. U.S. Pharmacopeia Releases New Edition of the Food Chemicals Codex
11. US Pharmacopeia releases new edition of the Food Chemicals Codex
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/21/2017)... , ... September 21, 2017 , ... ... their communities, nine governmental public health departments have been awarded five-year accreditation status ... mean that the benefits of being served by a PHAB-accredited health department ...
(Date:9/21/2017)... (PRWEB) , ... September 21, 2017 , ... The New ... with autism, announced today the election of Yie-Hsin Hung to the Board of Directors. ... join our Board of Directors. Ms. Hung is an invaluable addition to our team,” ...
(Date:9/21/2017)... ... September 21, 2017 , ... FlipBelt, the fitness brand that specializes ... to the athletic wear market with the launch of their FlipBelt Crops. , The ... essentials securely at their fingertips while at the gym, on the trail, or on-the-go. ...
(Date:9/20/2017)... ... September 20, 2017 , ... ... Prescott, Arizona, is now accredited by The Joint Commission for chemical dependency and ... accredits and certifies U.S. health care organizations that meet the commission’s rigorous standards. ...
(Date:9/20/2017)... ... September 20, 2017 , ... ... voice for people who have kidney disease. The theme “Describe a positive decision ... stories. Entrants needed to meet only one qualification— to have been diagnosed ...
Breaking Medicine News(10 mins):
(Date:9/12/2017)... FRANCISCO , Sept. 12, 2017  ValGenesis ... Management Solutions (VLMS), is pleased to announce the ... a member of its Board of Directors and ... ValGenesis VLMS enables life science companies to manage ... the use of paper in this process. Furthermore, ...
(Date:9/9/2017)... , Sept. 9, 2017  Eli Lilly and Company ... and secondary endpoint data for lasmiditan, an investigational, oral, ... demonstrated statistically significant improvements compared to placebo in the ... today at the 18th Congress of the International Headache ... "The data presented today demonstrate lasmiditan,s potential to ...
(Date:9/7/2017)... , Sept. 7, 2017 Caris Life ... on fulfilling the promise of precision medicine, today ... the benefits of its molecular profiling approach in ... comprehensive genomic profiling plus (CGP+) with Caris Molecular ... tumor on a molecular level, leading to more ...
Breaking Medicine Technology: